(general qualification of university entrance), 12 (subjectrelated entrance qualification), 10 (intermediate school-leaving certificate), and 9 (secondary-school qualification) years of school education, respectively. The sample could be divided into 89 participants (84%) with low and 15 (14%) with high occupational attainment (2 participants could not be classified) [5] . The mean Expanded Disability Status Scale score was 3.46 ± 1.44 (range 0.5-7.5). The mean disease duration (years since diagnosis) was 7.75 ± 7.44 years (range 0-32 years). Eighteen participants were receiving antidepressants. Compared to published cut-off values, the sample demonstrated high fatigue scores (Fatigue Scale for Motor and Cognitive Functions, FSMC [6]; mean = 71.56 ± 16.35; range = 35-100), whereas the depression value was within normal limits (mean = 21.17 ± 12.59; median = 19; range = 2-54).
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The study data showed no influence of gender, age, or disease duration on FoP. Furthermore, we found no variation in mean FoP-Q levels for different MS courses (relapsing-remitting MS, secondary-progressive MS, primary-progressive MS). This result suggests that FoP develops independently of the course that MS takes. Correlation analysis showed moderate to large associations of FoP-Q scales with depression (CES-D; 0.36 < r < 0.71) and with both action control subscales (Action Control Scale [7] ; preoccupation: 0.35 < r < 0.63, hesitation: 0.35 < r < 0.51). There were only small correlations between FoP-Q scales and the FSMC sum score and FSMC cognition score (0.27 < r < 0.31).
Hierarchical regression analysis predicting depression revealed a model in which 70% of the variance in the CES-D were explained by the following set of predictors (Table 1) . The most valuable predictor was the FoP-Q subscale affective reaction. The items of this subscale describe anxiety about various domains of life, anxiety triggers, and forms of expression of anxiety. The positive β-coefficient indicates a frequent coexistence of anxiety and depressive reaction patterns. The next most relevant predictor was the FSMC sum score, which points to the close relationship of this predominant MS symptom to the symptoms of depression. The coping scale of the FoP-Q appears to be a valuable predictor of depression as well. The inverse relationship suggests that the better the anxiety coping competencies, the lower the severity of depressive mood states. Moreover, we found the Action Control Scale factor preoccupation to be a relevant variable. The negative β-coefficient indicates a reciprocal relationship: the larger this component of state-orientated behaviour, the lower the success in depressive mood regulation. Finally, the variables of education and occupational attainment were included in the regression model. Both seem to have an indirect protective effect on the level of depression. These findings accord with those of Pavlou and Counte's [8] analysis of data on MS adjustment factors, such as attitudes, stereotypical beliefs, and disease knowledge. They found that a person's education level was a predictor of all 3 of these measures.
Anxiety disorders are widespread among patients with chronic physical diseases, such as diabetes mellitus, cancer, and rheumatic diseases. Studies based on psychosocial stress screenings and disease-specific questionnaires have concluded that one specific anxiety is central to the patient's life, i.e. the fear that the disease will progress, with all its consequences. Herschbach et al. [1] have called this the fear of progression (FoP). They defined FoP as a reactive, non-neurotic emotional response that patients are fully aware of. The fear is based on the personal experience of a lifethreatening or incapacitating illness, and is experienced with emotional, cognitive, behavioural, and physiological qualities [1] .
Multiple sclerosis (MS) is also a progressive disease with an unpredictable course. It is the most common cause of chronic neurological disability in young adults, with onset typically between the ages of 20 and 40 years [2] . According to our research, FoP seems to be underrecognized in people with MS. We aimed, therefore, to explore the relationship between FoP (Fear of Progression Questionnaire, FoP-Q [1] ) and depression (Center for Epidemiologic Studies Depression Scale, CES-D [3, 4] ), while controlling for demographic, clinical, and psychological variables.
The study sample (n = 106) showed typical demographic data for MS cohorts admitted to a neurological rehabilitation centre, with a predominance of females (76%) and a relapsing-remitting MS disease course (65%) (69 with relapsing-remitting MS, 13 with secondary-progressive MS, 21 with primary-progressive MS, 2 with clinically isolated syndrome, and 1 with undetermined MS course). The mean age of the participants was 45.44 ± 9.16 years (range 25-65 years) (81 females: 45.23 ± 9.64, 25 males: 46.12 ± 7.52). The duration of education was 10.67 ± 1.46 years (range Overall, our results can be interpreted as an indication that FoP is a meaningful emotional stressor in patients with MS, especially in those with depression. It seems to be wise to distinguish FoP from psychiatric-based anxiety disorders, because individuals with MS are confronted with a real threat, and their reaction pattern should be considered as a functional response to an extraordinary, everlasting life event. This distinction should be considered in psychotherapeutic treatments and, in our opinion, also applies to other MS-related anxiety disorders (e.g., fear of falling, fear of losing bladder control, fear of blindness).
The strong relationship between FoP scales and depression corresponds to previous findings, which had observed that persons with MS express more variability in their emotional reactions to the disease than other chronic illness groups [9] . Brown et al. [10] suggested that the high comorbidity of anxiety and depression in MS studies might reflect a causal relationship between these symptoms, and that they are part of a broader psychosomatic disorder (a mixed anxiety-depression disorder). That would imply that adjustment to MS and its challenges needs to be conceptualized therapeutically as a multidimensional psychological process.
Owing to the preliminary nature of our study, several shortcomings limit the generalizability of our findings, including the study's cross-sectional design, the missing control group and the exclusive use of self-reported measures. Therefore, future research aimed at exploring the precise temporal and causal relationships of our symptom comorbidity should use a prospective longitudinal design. Moreover, in the future, we plan to examine the concept of FoP (in relation to depression) in patients with chronic diseases that do not affect the CNS.
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